Table 7 Summary of microscopic findings at control and 1000 mg/kg/day-dosed rat for 90 days.

From: Safety assessment and gastrointestinal retention of orally administered cerium oxide nanoparticles in rats

  

Males

Females

Control

1000 mg/kg

Control

1000 mg/kg

Adrenal glands

Vacuolation, zona fasciculata

2(1 >)

1(1 >)

  

Heart

Cardiomyopathy

2(1 >)

0(1 >)

  

Infiltration, mononuclear cell

0(1 >)

1(1 >)

1(1 >)

0(1 >)

Kidneys

Basophilia, tubules

4(1 >)

1(1 >)

  

Cyst(s)

2(1 >)

1(1 >)

  

Dilation, pelvis

1(1 >)

0(1 >)

  

Infiltration, mononuclear cell

3(1 >)

2(1 >)

  

Nephropathy, focal

0(1 >)

1(1 >)

  

Mineralization

  

1(1 >)

0(1 >)

Liver

Infiltration, mononuclear cell

4(1 >)

4(1 >)

1(1 >)

1(1 >)

Lung with bronchi

Alveolar macrophage aggregation

1(1 >)

1(1 >)

1(1 >)

1(1 >)

Infiltration, eosinophil, perivascular

1(1 >)

0(1 >)

  

Pleural fibosis

1(1 >)

0(1 >)

  

Infiltration, mononuclear cell

  

0(1 >)

2(1 >)

Pigmented macrophages

  

0(1 >)

2(1 >)

Pancreas

Atrophy, acinar cell

2(1 >)

3(1 >)

  

Infiltration, mononuclear cell

1(1 >)

1(1 >)

  

Prostate

Infiltration, mononuclear cell

2(1 >)

6(1 >)

  

Skin

Congestion/hemorrhage

1(2 >)

0(2 >)

  

Erosion/ulcer

1(2 >)

0(2 >)

  

Granulomatous inflammation

1(3 >)

0(3 >)

  

Skin, inguinal

Erosion

1(1 >)

0(1 >)

  

Testes

Atrophy, tubular

1(1 >)

0(1 >)

  
  1. Data were expressed as number of animals showing histological abnormalities (number of findings in individual).